Technology Council, IVD Provisions Get Go-Ahead By House/Senate Conferees

A Medicare reform provision extending routine patient care coverage of breakthrough medical device trials would cost approximately $3.3 bil. less than the Congressional Budget Office originally scored, according to AdvaMed

More from Archive

More from Medtech Insight